| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ELVN | Enliven Therapeutics, Inc. | Heyman Richard A. | Director | Apr 15, 2024 | Sale | $19.99 | 1,270 | 25,383 | 137,235 | Apr 15, 2024, 07:03 PM | |
| ELVN | Enliven Therapeutics, Inc. | Heyman Richard A. | Director | Apr 11, 2024 | Sale | $25.03 | 5,045 | 126,279 | 138 | Apr 15, 2024, 07:03 PM | |
| ELVN | Enliven Therapeutics, Inc. | Heyman Richard A. | Director | Apr 11, 2024 | Sale | $25.00 | 649 | 16,225 | 28,567 | Apr 15, 2024, 07:03 PM | |
| ELVN | Enliven Therapeutics, Inc. | Heyman Richard A. | Director | Mar 19, 2024 | Sale | $14.50 | 1,270 | 18,419 | 143,470 | Mar 21, 2024, 06:41 PM | |
| RYZB | RayzeBio, Inc. | Heyman Richard A. | Director | Feb 26, 2024 | Option Exercise | $62.50 | 367,446 | 22,965,375 | 0 | Feb 27, 2024, 04:59 PM | |
| ELVN | Enliven Therapeutics, Inc. | Heyman Richard A. | Director | Feb 15, 2024 | Sale | $17.42 | 1,270 | 22,117 | 144,740 | Feb 20, 2024, 07:41 PM | |
| ELVN | Enliven Therapeutics, Inc. | Heyman Richard A. | Director | Jan 30, 2024 | Sale | $16.41 | 1,270 | 20,840 | 146,010 | Feb 01, 2024, 08:10 PM | |
| ELVN | Enliven Therapeutics, Inc. | Heyman Richard A. | Director | Dec 21, 2023 | Sale | $13.00 | 7 | 91 | 147,448 | Dec 26, 2023, 07:29 PM | |
| ELVN | Enliven Therapeutics, Inc. | Heyman Richard A. | Director | Dec 21, 2023 | Sale | $13.00 | 6 | 78 | 29,251 | Dec 26, 2023, 07:29 PM | |
| ELVN | Enliven Therapeutics, Inc. | Heyman Richard A. | Director | Dec 22, 2023 | Sale | $13.00 | 168 | 2,184 | 147,280 | Dec 26, 2023, 07:29 PM | |
| ELVN | Enliven Therapeutics, Inc. | Heyman Richard A. | Director | Dec 22, 2023 | Sale | $13.00 | 35 | 455 | 29,216 | Dec 26, 2023, 07:29 PM | |
| ELVN | Enliven Therapeutics, Inc. | Heyman Richard A. | Director | Dec 20, 2023 | Sale | $13.02 | 1,915 | 24,939 | 29,257 | Dec 21, 2023, 04:28 PM | |
| ELVN | Enliven Therapeutics, Inc. | Heyman Richard A. | Director | Dec 19, 2023 | Sale | $13.00 | 255 | 3,315 | 149,565 | Dec 21, 2023, 04:28 PM | |
| ELVN | Enliven Therapeutics, Inc. | Heyman Richard A. | Director | Dec 20, 2023 | Sale | $13.02 | 2,110 | 27,473 | 147,455 | Dec 21, 2023, 04:28 PM | |
| ORIC | Oric Pharmaceuticals, Inc. | Heyman Richard A. | Director | Sep 14, 2021 | Sale | $25.05 | 706 | 17,686 | 216,954 | Sep 16, 2021, 06:19 PM | |
| ORIC | Oric Pharmaceuticals, Inc. | Heyman Richard A. | Director | Sep 15, 2021 | Sale | $25.03 | 682 | 17,074 | 216,272 | Sep 16, 2021, 06:19 PM | |
| ORIC | Oric Pharmaceuticals, Inc. | Heyman Richard A. | Director | Sep 13, 2021 | Sale | $25.01 | 601 | 15,033 | 217,660 | Sep 14, 2021, 04:03 PM | |
| ORIC | Oric Pharmaceuticals, Inc. | Heyman Richard A. | Director | Sep 10, 2021 | Sale | $25.10 | 479 | 12,023 | 218,261 | Sep 14, 2021, 04:03 PM | |
| ORIC | Oric Pharmaceuticals, Inc. | Heyman Richard A. | Director | Sep 07, 2021 | Sale | $25.11 | 1,086 | 27,272 | 218,740 | Sep 09, 2021, 04:36 PM | |
| ORIC | Oric Pharmaceuticals, Inc. | Heyman Richard A. | Director | May 14, 2021 | Sale | $25.31 | 3,215 | 81,382 | 223,885 | May 18, 2021, 08:22 PM | |
| ORIC | Oric Pharmaceuticals, Inc. | Heyman Richard A. | Director | May 17, 2021 | Sale | $25.07 | 498 | 12,484 | 223,387 | May 18, 2021, 08:22 PM | |
| ORIC | Oric Pharmaceuticals, Inc. | Heyman Richard A. | Director | May 18, 2021 | Sale | $25.32 | 2,161 | 54,715 | 221,226 | May 18, 2021, 08:22 PM | |
| ORIC | Oric Pharmaceuticals, Inc. | Heyman Richard A. | Director | Apr 30, 2021 | Sale | $25.26 | 100 | 2,526 | 227,200 | Apr 30, 2021, 07:59 PM | |
| ORIC | Oric Pharmaceuticals, Inc. | Heyman Richard A. | Director | Apr 28, 2021 | Sale | $25.08 | 100 | 2,508 | 227,300 | Apr 30, 2021, 07:59 PM | |
| ORIC | Oric Pharmaceuticals, Inc. | Heyman Richard A. | Director | Apr 01, 2021 | Sale | $25.00 | 100 | 2,500 | 227,400 | Apr 05, 2021, 07:42 PM |
Menu